Brought to you by 
Innovative Metabolics takes in $5.5mm via Series A round
11 Jun 2007
Executive Summary
Anti-inflammatory device developer Innovative Metabolics (IMI) has raised $5.5mm in a Series A financing led by Morgenthaler Ventures. Foundation Medical Partners also participated.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com